GENKY DRUGSTORES CO., LTD. Consolidated Financial Results
for the Nine Months Ended March 20, 2021
[Japanese GAAP]
April 20, 2021
Company name: Genky DrugStores Co., Ltd.
Stock exchange listing: Tokyo Stock Exchange
Code number: 9267
URL: http://www.genkydrugstores.co.jp
Representative: Kenichi Fujinaga, President
Contact: Takeshi Tsunemi, Executive Officer, Treasurer and General Manager, IR Division
Phone: +81-776-67-5240
Scheduled date of filing quarterly securities report: April 30, 2021
Scheduled date of commencing dividend payments: ―
Availability of supplementary briefing material on quarterly financial results: Available
Schedule of quarterly financial results briefing session: Scheduled (for institutional investors and analysts)
(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Nine Months Ended March 20, 2021 (June 21, 2020 to March 20, 2021)
(1) Consolidated Operating Results | (% indicates changes from the previous corresponding period.) | ||||||||
Net income | |||||||||
Net sales | Operating income | Ordinary income | attributable to | ||||||
owners of parent | |||||||||
Nine months ended | Million yen | % | Million yen | % | Million yen | % | Million yen | % | |
March 20, 2021 | 103,450 | 20.0 | 4,646 | 90.2 | 4,860 | 82.3 | 3,412 | 98.6 | |
March 20, 2020 | 86,202 | 12.8 | 2,442 | (15.4) | 2,666 | (14.7) | 1,718 | (20.0) |
(Note) Comprehensive income: Nine months ended March 20, 2021: ¥3,428 million (101.5%) Nine months ended March 20, 2020: ¥1,701 million ((20.1)%)
Net income | Diluted net | |
per share | income per share | |
Nine months ended | Yen | Yen |
March 20, 2021 | 224.86 | 224.62 |
March 20, 2020 | 113.24 | ― |
(Note) Diluted net income per share for the nine months ended March 20, 2020 is not recorded because there were no dilutive shares with a dilutive effect.
(2) Consolidated Financial Position
Total assets | Net assets | Equity ratio | |
Million yen | Million yen | % | |
As of March 20, 2021 | 82,521 | 30,742 | 37.2 |
As of June 20, 2020 | 83,145 | 27,685 | 33.3 |
(Reference) Equity: As of March 20, 2021: ¥30,724 million As of June 20, 2020: ¥27,676 million
2. Dividends
Annual dividends | ||||||
1st | 2nd | 3rd | Year-end | Total | ||
quarter-end | quarter-end | quarter-end | ||||
Yen | Yen | Yen | Yen | Yen | ||
Fiscal 2019 | － | 12.50 | － | 12.50 | 25.00 | |
Fiscal 2020 | － | 12.50 | － | |||
Fiscal 2020 | 12.50 | 25.00 | ||||
(Forecast) | ||||||
(Note) Revision to the forecast for dividends announced most recently: No |
3. Consolidated Financial Results Forecast for the Fiscal Year Ending June 20, 2021 (June 21, 2020 to June 20, 2021)
(% indicates changes from | the previous | fiscal year.) | ||||||||
Net income | Net income | |||||||||
Net sales | Operating income | Ordinary income | attributable to | |||||||
per share | ||||||||||
owners of parent | ||||||||||
Million yen | % | Million yen | % | Million yen | % | Million yen | % | Yen | ||
Full year | 143,000 | 15.7 | 6,200 | 42.8 | 6,600 | 44.5 | 4,500 | 63.3 | 296.50 |
(Note) Revision to the financial results forecast announced most recently: No
Notes:
-
Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting in changes in scope of consolidation): No
Newly consolidated: None (Company Name); Removed from consolidation: None (Company Name) - Accounting policies adopted specially for the preparation of quarterly consolidated financial statements: No
- Changes in accounting policies, changes in accounting estimates and retrospective restatement
- Changes in accounting policies due to the revision of accounting standards: No
- Changes in accounting policies other than 1) above: No
- Changes in accounting estimates: No
- Retrospective restatement: No
- Total number of issued shares (common stock)
-
Total number of issued shares at the end of the period (including treasury stock): As of March 20, 2021: 15,477,484 shares
As of June 20, 2020: 15,477,484 shares - Total number of treasury stock at the end of the period:
As of March 20, 2021: 300,324 shares
As of June 20, 2020: 300,159 shares
3) Average number of shares during the period:
Nine months ended March 20, 2021: 15,177,239 shares
Nine months ended March 20, 2020: 15,177,339 shares
*These quarterly financial results are outside the scope of quarterly reviews by a certified public accountant or an audit corporation.
* Explanation of the proper use of financial results forecast and other notes
The earnings forecasts and other forward-looking statements herein are based on information that is available and certain assumptions deemed reasonable as of the date of publication of this document. Actual results may differ significantly from these forecasts due to a wide range of factors.
Attachments
- Original document
- Permalink
Disclaimer
Genky DrugStores Co. Ltd. published this content on 20 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 April 2021 07:06:09 UTC.
